Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Cynthia Besch-Williford"'
Publikováno v:
Breast Cancer Research and Treatment. 192:53-63
Most hormone-dependent human breast cancers develop resistance to anti-hormone therapy over time. Our goal was to identify novel treatment strategies to avoid this drug resistance and thereby control hormone-dependent breast cancer.Sulforhodamine B a
Autor:
Patri Vergara, Gregory Ballard, Cynthia Besch-Williford, Nobuhito Hayashimoto, Cynthia Pekow, Ana Perez, Katja Schmidt, William Shek, Martin Toft, Atsushi Yoshiki
Publikováno v:
ILAR journal.
ICLAS Laboratory Animal Quality Network (LAQN) programs currently consist of the Performance Evaluation Program (PEP), which focuses on microbial monitoring by and for laboratory animal diagnostic laboratories, and the Genetic Reference Monitoring Pr
Publikováno v:
Cancer Reports and Reviews. 4
Autor:
Anthony M Belenchia, Matthew T Cook, Cynthia Besch-Williford, Yayun Liang, Salman M. Hyder, Rolf A. Brekken
Publikováno v:
Breast Cancer : Targets and Therapy
Yayun Liang,1 Cynthia Besch-Williford,2 Matthew T Cook,3 Anthony Belenchia,4 Rolf A Brekken,5 Salman M Hyder11Department of Biomedical Sciences and Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA; 2IDEXX BioAnalytics,
Autor:
Kevin L. Fritsche, Cynthia Besch-Williford, George E. Rottinghaus, Y. C. Li, Nicholas J.E. Starkey, Monica Peña-Luna, Dennis B. Lubahn, Nathaniel W. Mahloch
3,3′-Diindolylmethane (DIM) is an acid-derived dimer of indole-3-carbinol, found in many cruciferous vegetables, such as broccoli, and has been shown to inhibit prostate cancer (PCa) in several in vitro and in vivo models. We demonstrated that DIM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b680018752928de05bebd40e1792e85c
Publikováno v:
Journal of the Endocrine Society
Mutations in the tumor suppressor p53 gene are frequently associated with various cancers, including human breast cancer. Unlike wild-type p53 (wtp53), mutant p53 protein (mtp53) fails to promote apoptosis, resulting in tumor cell survival and resist
Publikováno v:
Cancer Research. 76:P1-16
Clinical trials and epidemiological evidence show that combined estrogen (E) and progestin (P) hormone replacement therapy (HRT) increases the risk of breast cancer in postmenopausal women, whereas HRT containing E alone does not. Tumor progression i
Autor:
Frederick S. vom Saal, Cynthia Besch-Williford, Julia A. Taylor, Ashley F Berendzen, Maren Bell Jones, William A. Ricke
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 11
International Journal of Molecular Sciences, Vol 21, Iss 3902, p 3902 (2020)
Volume 21
Issue 11
International Journal of Molecular Sciences, Vol 21, Iss 3902, p 3902 (2020)
Obstructive voiding disorder (OVD) occurs during aging in men and is often, but not always, associated with increased prostate size, due to benign prostatic hyperplasia (BPH), prostatitis, or prostate cancer. Estrogens are known to impact the develop
Publikováno v:
Breast Cancer : Targets and Therapy
Yayun Liang,1 Benford Mafuvadze,1 Cynthia Besch-Williford,2 Salman M Hyder1 1Deparment of Biomedical Sciences and Dalton Cardiovascular Research Center, Columbia, MO, USA; 2IDEXX BioResearch, Columbia, MO, USA Background: Between 30 and 40% of human
Autor:
Sandy Goyette, Mark R. Ellersieck, Matthew Cook, Salman M. Hyder, Cynthia Besch-Williford, Benford Mafuvadze
Publikováno v:
Oncology Reports. 35:825-832
Postmenopausal women undergoing hormone-replacement therapy containing both progestins and estrogens are at an increased risk of developing breast cancer compared with women taking estrogen alone. We recently demonstrated that medroxyprogesterone ace